{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T03:52:19Z","timestamp":1784605939624,"version":"3.55.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T00:00:00Z","timestamp":1581033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"DOI":"10.3389\/fcell.2020.00057","type":"journal-article","created":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T09:54:11Z","timestamp":1581069251000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Sclerostin and Its Associations With Bone Metabolism Markers and Sex Hormones in Healthy Community-Dwelling Elderly Individuals and Adolescents"],"prefix":"10.3389","volume":"8","author":[{"given":"Yang","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinwei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqin","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuntao","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bihua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenlin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,2,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1210\/jc.2011-2152","article-title":"Sclerostin and its association with physical activity, age, gender, body composition, and bone mineral content in healthy adults.","volume":"97","author":"Amrein","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1002\/jbmr.479","article-title":"Determinants of serum sclerostin in healthy pre- and postmenopausal women.","volume":"26","author":"Ardawi","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1210\/en.2007-0270","article-title":"Targeting the Wnt\/beta-catenin pathway to regulate bone formation in the adult skeleton.","volume":"148","author":"Baron","year":"2007","journal-title":"Endocrinology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1002\/jbmr.3160","article-title":"The Lrp4R1170Q homozygous knock-in mouse recapitulates the bone phenotype of sclerosteosis in humans.","volume":"32","author":"Boudin","year":"2017","journal-title":"J. Bone Miner. Res."},{"key":"B5","doi-asserted-by":"crossref","DOI":"10.1002\/jbmr.3923","article-title":"Sclerostin antibody treatment increases bone mass and normalizes circulating phosphate levels in growing Hyp mice.","author":"Carpenter","year":"2019","journal-title":"J. Bone Miner. Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1530\/EJE-14-0106","article-title":"Gender differences in sclerostin and clinical characteristics in type 1 diabetes mellitus.","volume":"171","author":"Catalano","year":"2014","journal-title":"Eur. J. Endocrinol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab treatment in postmenopausal women with osteoporosis.","volume":"375","author":"Cosman","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"4736","DOI":"10.1210\/jc.2013-2106","article-title":"Circulating sclerostin levels and markers of bone turnover in Chinese-American and white women.","volume":"98","author":"Costa","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1007\/s00198-017-4104-2","article-title":"Circulating levels of dickkopf-1, osteoprotegerin and sclerostin are higher in old compared with young men and women and positively associated with whole-body bone mineral density in older adults.","volume":"28","author":"Coulson","year":"2017","journal-title":"Osteoporos. Int."},{"key":"B10","doi-asserted-by":"publisher","first-page":"3873","DOI":"10.1210\/jc.2013-2113","article-title":"Association of circulating sclerostin with bone mineral mass, microstructure, and turnover biochemical markers in healthy elderly men and women.","volume":"98","author":"Durosier","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1210\/jc.2016-2371","article-title":"High sclerostin and dickkopf-1 (DKK-1) serum levels in children and adolescents with type 1 diabetes mellitus.","volume":"102","author":"Faienza","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B12","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00198-012-1978-x","article-title":"Association of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in postmenopausal women: the OFELY study.","volume":"24","author":"Garnero","year":"2013","journal-title":"Osteoporos. Int."},{"key":"B13","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.devcel.2005.02.017","article-title":"Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation.","volume":"8","author":"Glass","year":"2005","journal-title":"Dev. Cell"},{"key":"B14","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s00223-019-00526-z","article-title":"Elevated bone remodeling markers of CTX and P1NP in addition to sclerostin in patients with X-linked hypophosphatemia: a cross-sectional controlled study.","volume":"104","author":"Hansen","year":"2019","journal-title":"Calcif. Tissue Int."},{"key":"B15","doi-asserted-by":"publisher","first-page":"E665","DOI":"10.1210\/jc.2013-2086","article-title":"Associations of serum sclerostin and polymorphisms in the SOST gene with bone mineral density and markers of bone metabolism in postmenopausal Chinese women.","volume":"99","author":"He","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/s00198-011-1669-z","article-title":"Sclerostin levels during growth in children.","volume":"23","author":"Kirmani","year":"2012","journal-title":"Osteoporos. Int."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1172\/JCI28551","article-title":"Regulation of bone mass by Wnt signaling.","volume":"116","author":"Krishnan","year":"2006","journal-title":"J. Clin. Invest."},{"key":"B18","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1359\/jbmr.080216","article-title":"Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength.","volume":"23","author":"Li","year":"2008","journal-title":"J. Bone Miner. Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/s00223-016-0160-4","article-title":"Decreased plasma levels of sclerostin but not Dickkopf-1 are associated with an increased prevalence of osteoporotic fracture and lower bone mineral density in postmenopausal Korean women.","volume":"99","author":"Lim","year":"2016","journal-title":"Calcif. Tissue Int."},{"key":"B20","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1056\/NEJMoa1305224","article-title":"Romosozumab in postmenopausal women with low bone mineral density.","volume":"370","author":"McClung","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1210\/jc.2009-2283","article-title":"Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women.","volume":"95","author":"Mirza","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/jbmr.128","article-title":"Regulation of circulating sclerostin levels by sex steroids in women and in men.","volume":"26","author":"Modder","year":"","journal-title":"J. Bone Miner. Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/jbmr.217","article-title":"Relation of age, gender, and bone mass to circulating sclerostin levels in women and men.","volume":"26","author":"Modder","year":"","journal-title":"J. Bone Miner. Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/cen.12364","article-title":"Clinical and endocrine correlates of circulating sclerostin levels in patients with type 1 diabetes mellitus.","volume":"80","author":"Neumann","year":"2014","journal-title":"Clin. Endocrinol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1002\/jbmr.3036","article-title":"Romosozumab improves bone mass and strength while maintaining bone quality in ovariectomized cynomolgus monkeys.","volume":"32","author":"Ominsky","year":"2017","journal-title":"J. Bone Miner. Res."},{"key":"B26","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz254","article-title":"Increased serum sclerostin levels in patients with active acromegaly.","author":"Pekkolay","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1002\/jbmr.2489","article-title":"The effect of discontinuing treatment with blosozumab: follow-up results of a Phase 2 randomized clinical trial in postmenopausal women with low bone mineral density.","volume":"30","author":"Recknor","year":"2015","journal-title":"J. Bone Miner. Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1210\/edrv.23.3.0465","article-title":"Sex steroids and the construction and conservation of the adult skeleton.","volume":"23","author":"Riggs","year":"2002","journal-title":"Endocr. Rev."},{"key":"B29","doi-asserted-by":"publisher","first-page":"22","DOI":"10.5582\/ddt.2019.01011","article-title":"Study of correlation of level of expression of Wnt signaling pathway inhibitors sclerostin and dickkopf-1 with disease activity and severity in rheumatoid arthritis patients.","volume":"13","author":"Singh","year":"2019","journal-title":"Drug Discov. Ther."},{"key":"B30","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1002\/jbmr.1823","article-title":"Lower fracture risk in older men with higher sclerostin concentration: a prospective analysis from the MINOS study.","volume":"28","author":"Szulc","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/pedi.12288","article-title":"Sclerostin distribution in children and adolescents with type 1 diabetes mellitus and correlation with bone metabolism and bone mineral density.","volume":"17","author":"Tsentidis","year":"2016","journal-title":"Pediatr. Diabetes"},{"key":"B32","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1084\/jem.20031454","article-title":"Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist.","volume":"199","author":"Van Bezooijen","year":"2004","journal-title":"J. Exp. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1002\/jbmr.474","article-title":"Patients with sclerosteosis and disease carriers: human models of the effect of sclerostin on bone turnover.","volume":"26","author":"Van Lierop","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1002\/jbmr.1794","article-title":"Van Buchem disease: clinical, biochemical, and densitometric features of patients and disease carriers.","volume":"28","author":"Van Lierop","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1210\/jcem.84.10.6079","article-title":"A critical evaluation of simple methods for the estimation of free testosterone in serum.","volume":"84","author":"Vermeulen","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B36","doi-asserted-by":"publisher","first-page":"4030","DOI":"10.1210\/jc.2013-2143","article-title":"Elevated sclerostin levels are associated with vertebral fractures in patients with type 2 diabetes mellitus.","volume":"98","author":"Yamamoto","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B37","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00223-019-00542-z","article-title":"Serum sclerostin and bone morphogenetic protein-2 levels in patients with ankylosing spondylitis: a meta-analysis.","volume":"105","author":"Yang","year":"2019","journal-title":"Calcif. Tissue Int."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcell.2020.00057\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T09:54:13Z","timestamp":1581069253000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcell.2020.00057\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,7]]},"references-count":37,"alternative-id":["10.3389\/fcell.2020.00057"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2020.00057","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,7]]},"article-number":"57"}}